GLP-1 Receptor Agonists May Have Little or No Effect on Obesity-Related Cancers - Gastroenterology Advisor

GLP-1 Receptor Agonists May Have Little or No Effect on Obesity-Related Cancers  Gastroenterology AdvisorPopular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds  NDTVHow GLP-1s really affect breast, other cancer risk: Latest evidence  Medical News TodayRon Lanton III, Esq  Drug TopicsKey Safety and Dosing Considerations for GLP-1 Agonists in Oncology Care  Pharmacy Times